MIT Sloan BioInnovations 2006

2004
2005
2006
2007
2008
2009
2010

MIT Sloan BioInnovations Conference Saturday, May 6, 2006

MIT Sloan School of Management
Kendall Square, Cambridge MA

Senior industry management, investors, and academics from the Massachusetts biotechnology community convene for a day of substantive idea exchange.

The Agenda

8:00	Registration and Morning Networking
9:00	Opening Remarks
	Introduction of Morning Keynote Speaker Anthony J. Sinskey, ScD, Professor of Microbiology and Health Sciences & Technology, Massachusetts Institute of Technology
	Morning Keynote Speaker John Glaser, PhD, Vice President and CIO, Partners HealthCare System
10:00	Networking
10:30	Panel Session 1 Technology Developments in Diagnostic Imaging Panel Participants Azad Anand, MD, Radiologist, Long Island Diagnostic Imaging Alan Jasanoff, PhD, Assistant Professor, Massachusetts Institute of Technology Michael Reitermann, MBA, President, Siemens Molecular Imaging Division, Siemens Medical Solutions Gary Strangman, PhD, Assistant Professor, Harvard Medical School Jean-Luc Vanderheyden, PhD, Global Molecular Imaging Leader, Technology and Medical Office, GE Healthcare Error Prevention in the Next Generation Hospital – A discussion on the current and future role of clinical informatics. Panel Moderator Zebadiah Kimmel, MD, MS, Post-Doctoral Fellow in Medical Informatics, Harvard-MIT Division of Health Sciences and Technology Panel Participants Barry Blumenfeld, MD, MS, Associate Director for Clinical Informatics R&D, Partners Healthcare System Robert A. Greenes, MD, PhD, Director, Decision Systems Group, Brigham and Women's Hospital Kris Joshi, PhD, Senior Strategist, IBM Global Sales and Distribution Sumit Nagpal, Founder, President and CEO, Wellogic
12:00	Lunch
	Introduction of Lunchtime Keynote Speaker Frank L. Douglas, MD, PhD, Executive Director, MIT Center for BioMedical Innovations and Professor of the Practice, MIT Schools of Management, Engineering, and Science
	Lunchtime Keynote Speaker Una S. Ryan, PhD, Chair, Massachusetts Biotechnology Council and CEO, AVANT Immunotherapeutics, Inc.
2:00	Panel Session 2 Technologies to Enable Treatment in the Developing World Panel Moderator David Chin, MD, MBA, Partner, Healthcare Advisory Practice, PricewaterhouseCoopers' Panel Participants Elizabeth Bailey, MPP, Principal, Commons Capital Kate Carr, President and CEO, Accelerate Brain Cancer Cure (ABC2) Thomas Evans, MD, Head of Infectious Diseases, Novartis Institutes for BioMedical Research Kris Joshi, PhD, Senior Strategist, IBM Global Sales and Distribution Developments in Genomics and Personalized Medicine – How understanding disease and patient characteristics will impact current treatment paradigms. Panel Moderator Steven Wardell, MBA, MPhil, Principal, Apeiron Partners, LLC Panel Participants J. Carl Barrett, PhD, Global Head of BioMarker Development Oncology, Novartis Institutes for BioMedical Research, Inc. George Church, PhD, Professor of Genetics and Director of the Center for Computational Genetics, Harvard Medical School Raju Kucherlapati, PhD, Scientific Director, Harvard-Partners Center for Genetics and Genomics Glenn A. Miller, PhD, Vice President and General Manager, Genzyme Analytical Services
3:00	Networking
3:30	Panel Session 3 Bio-Surveillance: Monitoring Bioterrorist and Public Health Threats Panel Participants Leslie Chun, MD, MBA, Associate Medical Director, Health Dialog Analytic Solutions Alfred DeMaria, Jr, MD, Assistant Commissioner, Chief Medical Officer, Director of the Bureau of Communicable Disease Control and State Epidemiologist, Massachusetts Department of Public Health Kenneth Mandl, MD, MPH, Director, Center for Biopreparedness, Children's Hospital Boston Jeff Moore, PhD, Associate, Kauffman Fellow, RCT BioVentures Cost Improvements in Healthcare – Cutting costs and increasing efficiencies in healthcare through technology. Panel Moderator Ernst R. Berndt, PhD, Louis B. Seley Professor of Applied Economics, MIT Sloan School of Management Panel Participants A. Bruce Campbell, MD, PhD, Chief Health Services Officer, D2Hawkeye Joseph DiMasi, PhD, Director of Economic Analysis, Tufts University Randall W. Lutter, PhD, Associate Commissioner for Policy and Planning, FDA Amir Nashat, PhD, Principal, Polaris Venture Partners